Tracon Pharmaceuticals Inc Expected To Post A Loss Of 35 Cents A Share: Earnings Preview

TRACON Pharmaceuticals

21/02/2022 15:15

* TRACON Pharmaceuticals Inc  TCON.OQ   TCON.O  is expected
to show a rise in quarterly revenue when it reports  results on
February 23 (estimated). 
    * The San Diego California-based  company is expected to
report
revenue of $66.67 thousand, according to the mean estimate from
6 analysts, based on Refinitiv data.  
    * ​Refinitiv's mean analyst estimate for TRACON
Pharmaceuticals
Inc is for a loss of 35 cents per share. For the same quarter
last year, the company reported a loss of 31 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for TRACON
Pharmaceuticals Inc is $11​, about 78.1% above​ its last closing
price of $2.41. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2021  -0.32       -0.32      -0.38     Missed  -17.2
 Jun. 30 2021  -0.32       -0.31      -0.58     Missed  -86.2
 Mar. 31 2021  -0.30       -0.30      -0.33     Missed  -8.2​
 Dec. 31 2020  -0.44       -0.41      -0.31     Beat    23.6
 ​​Sep.        -0.64       -0.65      -0.38     Beat    41.5
 30 2020                                                
 Jun. 30 2020  -0.73       -0.73      -0.70     Beat    3.7​
 Mar. 31 2020  -1.12       -1.13      -0.78     Beat    31.1
 Dec. 31 2019  -1.65       -1.66      -1.25     Beat    24.9
 This summary was machine generated February 21 at 15:15 GMT. 
All figures in US dollars  unless otherwise stated